Thus, our data show that expression of EZH2 is regulated by the chemotherapeutic agents such as CPT and irradiation and that the effects of these treatments are substantially affected by the intactness of p53 and/or RB pathways in PCa cells. The gene discussed is TP53; the disease is posterior cortical atrophy.